MedPath

Effect of fixed growth modification correctors to treat mild to moderate misaligned bite (malocclusion) in adolescents

Not Applicable
Conditions
Oral Health
Class II malocclusion
Registration Number
ISRCTN57079737
Lead Sponsor
niversity of Alberta
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
59
Inclusion Criteria

1. Females aged 10-13 years old and males aged 10-14 years old, with first premolars and first permanent molars, fully erupted
2. Class II molar relationship or at least ½ cusp on both sides
3. Dental crowding = 6mm
4. Overbite = 1mm

Exclusion Criteria

1. Patients with missing/unerupted permanent first premolars and molars
2. Gingival recession (below CEJ)
3. TMJ trauma syndromes
4. History of Class II corrective orthodontics

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Evaluating maxillofacial, dentoalveolar bone remodeling, and tooth position changes associated with FCC treatment using fused MRI-CBCT images and fused CBCT-CBCT<br>2. Evaluate TMJ disc remodeling and disc-condyle relationship changes associated with FCC treatment using Fused MRI-CBCT images.<br>3. Evaluate TMJ clinical function changes associated with FCC treatment using a scoring scale to detect the severity of any dysfunction. <br><br>The dental assessments will be conducted at all time points, whereas the TMJ assessments will be conducted at T1, T2, T3 & T4.<br><br>Timepoints:<br>T1: Baseline records for all groups at the enrolment date<br>T2: 12 months after T1 (before full bonded orthodontic treatment for all groups)<br>T3: 18 – 30 months after T2 (after debonding of orthodontic treatment for all groups)<br>T4: 24 months after T3
Secondary Outcome Measures
NameTimeMethod
1. Evaluating gingival attachment and periodontal condition changes associated with FCC treatment, using Clinical assessment at all 4 assessment times (T1, T2, T3, T4) <br>2. Evaluate the FCCs impact on participants' quality of life associated with FCC treatment using a self-reported Questionnaire:<br>Patients will be provided with a questionnaire to evaluate their overall experience during the FCC treatment. Patients will be asked to answer this survey at all 4 assessment times (T1, T2, T3, T4).
© Copyright 2025. All Rights Reserved by MedPath